The 340B Discount Program: Outpatient Prescription Dispensing Patterns Through Contract Pharmacies In 2012
Authors:
- 1 November 2014
- journal article
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 33 (11) , 2012-2017
Abstract
Section 340B of the Public Health Service Act provides qualified organizations serving vulnerable populations with deep discounts for some outpatient medications. A 2010 regulatory change widely expanded the 340B program’s reach, allowing these organizations to contract with retail pharmacies to dispense medications for eligible patients. Little is known about which medications are dispensed by contract pharmacies under the expanded program. We provide the first comparison of 340B prescriptions and all prescriptions dispensed in contract pharmacies. We used 2012 data from Walgreens, the national leader in 340B contract pharmacies. Medications used to treat chronic conditions such as diabetes, high cholesterol levels, asthma, and depression accounted for an overwhelming majority of all prescriptions dispensed at Walgreens as part of the 340B program. A higher percentage of antiretrovirals used to treat HIV/AIDS were dispensed through 340B prescriptions than through all prescriptions dispensed at Walgreens....Keywords
This publication has 8 references indexed in Scilit:
- Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical OncologyJournal of Oncology Practice, 2014
- Vertical Integration: Hospital Ownership Of Physician Practices Is Associated With Higher Prices And SpendingHealth Affairs, 2014
- The impact of patient assistance programs and the 340B Drug Pricing Program on medication cost.2014
- Hospitals, Market Share, and ConsolidationJAMA, 2013
- Exclusion of orphan drugs for certain covered entities under 340B Program. Final rule.2013
- Cost Consequences of the 340B Drug Discount ProgramJAMA, 2013
- Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy MedicationsJournal of Managed Care Pharmacy, 2009
- Prescription Drug Spending Trends In The United States: Looking Beyond The Turning PointHealth Affairs, 2008